Dyne Therapeutics, Inc.
DYN
$18.44
$0.070.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -451.71M | -446.21M | -423.80M | -412.89M | -367.13M |
| Total Depreciation and Amortization | 2.10M | 2.05M | 1.98M | 1.89M | 1.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.80M | 44.36M | 43.29M | 40.30M | 35.88M |
| Change in Net Operating Assets | -37.43M | -3.40M | 2.82M | 11.13M | 9.74M |
| Cash from Operations | -442.24M | -403.21M | -375.71M | -359.56M | -319.73M |
| Capital Expenditure | -19.95M | -20.71M | -21.30M | -2.37M | -3.17M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.65M | -8.04M | -24.44M | -24.81M | -19.62M |
| Cash from Investing | -32.60M | -28.75M | -45.74M | -27.18M | -22.78M |
| Total Debt Issued | 155.04M | 148.26M | 98.80M | 98.80M | -- |
| Total Debt Repaid | -579.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 602.68M | 742.61M | 364.73M | 164.86M | 542.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.01M | -558.00K | -549.00K | -- | -- |
| Cash from Financing | 756.13M | 890.31M | 462.98M | 263.66M | 542.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 281.29M | 458.35M | 41.53M | -123.08M | 200.24M |